ASND earnings
Ascendis Pharma (ASND) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
ASND earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | 3.29 | 1.71 | 92.40% | $344.90M |
| Q1 2026 | May 7, 2026 | 0.32 | 0.19 | 70.58% | $250.66M |
| Q4 2025 | Feb 11, 2026 | -0.64 | -0.06 | -966.67% | $245.18M |
| Q3 2025 | Nov 12, 2025 | -1.17 | -0.41 | -185.37% | $213.63M |
| Q2 2025 | Aug 7, 2025 | -0.93 | -1.42 | 34.51% | $158.04M |
| Q1 2025 | May 1, 2025 | -1.66 | -1.56 | -6.41% | $100.95M |
| Q4 2024 | Feb 12, 2025 | -0.68 | -1.20 | 43.33% | $173.92M |
| Q3 2024 | Nov 14, 2024 | -1.81 | -1.83 | 1.15% | $57.83M |
| Q2 2024 | Sep 3, 2024 | -2.05 | -1.54 | -33.12% | $36.00M |
| Q1 2024 | May 2, 2024 | -2.48 | -1.62 | -53.33% | $95.89M |
| Q4 2023 | Feb 7, 2024 | -1.66 | -2.19 | 24.14% | $137.70M |
| Q3 2023 | Nov 7, 2023 | -3.08 | -2.55 | -21.01% | $48.03M |
| Sep 5, 2023 | -2.35 | -2.68 | 12.31% | – | |
| Apr 27, 2023 | -2.18 | -2.93 | 25.56% | – | |
| Feb 16, 2023 | -3.96 | -2.74 | -44.53% | – | |
| Nov 2, 2022 | -3.05 | -2.52 | -21.03% | – | |
| Aug 10, 2022 | -1.50 | -2.19 | 31.46% | – | |
| May 11, 2022 | -2.31 | -2.09 | -10.50% | – | |
| Mar 2, 2022 | -2.06 | -2.57 | 20.09% | – | |
| Nov 10, 2021 | -1.69 | -2.63 | 35.81% | – |
- ASND reports next on Nov 11, 2026, with EPS of 0.98 expected.
- ASND beat EPS estimates in 21 of its last 45 reports.
Updated 2026-11-03 00:45 UTC